TP53 and colorectal carcinoma: RRP15 KD inhibited Wnt/β-catenin signaling in both p53 proficient and deficient CRC cells, while p53 co-deletion only partially reversed the inhibitory effects to Wnt/β-catenin targets transcription induced by RRP15 KD (Fig. S11).